Catch up on the top radiology content of the past week.
|Articles|June 23, 2014
Guidelines, Process Clash: 2014 Breast Cancer Screening Survey Results
Author(s)Diagnostic Imaging Staff
What’s the preferred breast cancer screening modality? When should patients begin screening mammograms? Are guidelines being considered? We compiled the data.
Advertisement
[[{"type":"media","view_mode":"media_crop","fid":"25331","attributes":{"alt":"","class":"media-image","id":"media_crop_2606298220343","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2310","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"line-height: 1.538em;","title":" ","typeof":"foaf:Image"}}]]
The breast cancer screening debate is ongoing, but the results of our 2014 Breast Cancer Screening Survey are in. We polled readers from Diagnostic Imaging and
As expected, mammography is the most preferred method of screening. Part of the controversy about breast cancer screening is the recommended age of biennial screening for average-risked women, which the United States Preventive Services Task Force (USPSTF) recommends beginning at age 50, however, almost half of our respondents recommend beginning biennial screening at age 40. The USPSTF is in the process of
Almost all respondents (91 percent) recommend supplemental screening for women at high-risk of breast cancer. Ultrasound was the supplemental modality of choice for 37 percent of the respondents, with MRI coming close behind at 35 percent.
Advertisement
Related to this article
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Catch up on the top radiology content of the past week.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
In the third of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss recent developments with autonomous AI in breast imaging and share their perspective on the overall potential of AI to help mitigate the radiologist shortage.
For patients with hepatocellular carcinoma (HCC), perfusion beyond tumor margin on contrast-enhanced ultrasound that exceeds gray-scale ultrasound tumor measurement by 5 mm is associated with a 76 percent higher risk of worse recurrence-free survival, according to newly published research.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
What New Dosimetry Data Reveals About 177Lu-Edotreotide for GEP-NET Treatment
2
Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference
3
Diagnostic Imaging’s Weekly Scan: October 4 — October 10
4
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 3
5